BAO D DAO
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- Antioch, CA
- NPI
- 1033349485
- Received
- $33,713 in 1,548 records, 2019 to 2025
- As principal investigator
- $552 of research payments to others in 7 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 259 | $6,114 |
| 2024 | General payment | 262 | $5,974 |
| 2023 | General payment | 243 | $5,451 |
| 2022 | General payment | 225 | $4,540 |
| 2021 | General payment | 209 | $4,142 |
| 2020 | General payment | 159 | $3,127 |
| 2019 | General payment | 191 | $4,363 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 1,520 | $32,286 |
| Consulting Fee | 1 | $1,005 |
| Education | 27 | $421 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Takeda Pharmaceuticals U.S.A., Inc. | $36 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-12-19 | EMD Serono, Inc. | $33 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-18 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-12-17 | PharmaEssentia USA Corporation | $27 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-12-17 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-12-16 | Celgene Corporation | $24 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-12-15 | Novartis Pharmaceuticals Corporation | $31 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-12-15 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-12-12 | GENZYME CORPORATION | $38 | Food and Beverage | In-kind items and services | WAYRILZ Drug, Immunology | 2025 | |
| 2025-12-12 | ARRAY BIOPHARMA INC | $18 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-12-11 | Merck Sharp & Dohme LLC | $33 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-12-10 | Tempus AI, Inc | $18 | Food and Beverage | In-kind items and services | XT CDX Device, ONCOLOGY | 2025 | |
| 2025-12-09 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-12-09 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-12-09 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-12-04 | BeOne Medicines USA, Inc. | $28 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-12-02 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-11-26 | ARRAY BIOPHARMA INC | $19 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-11-20 | Takeda Pharmaceuticals U.S.A., Inc. | $34 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-11-20 | Octapharma USA, Inc. | $16 | Food and Beverage | In-kind items and services | OCTAGAM IMMUNE GLOBULIN (HUMAN) Biological, IMMUNOLOGY | 2025 | |
| 2025-11-19 | Spectrum Pharmaceuticals Inc. | $39 | Food and Beverage | In-kind items and services | ROLVEDON Drug, Oncology | 2025 | |
| 2025-11-19 | Genentech USA, Inc. | $34 | Food and Beverage | In-kind items and services | Tecentriq Hybreza Biological, BioOncology | 2025 | |
| 2025-11-17 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-11-17 | Takeda Pharmaceuticals U.S.A., Inc. | $3 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-11-13 | Eisai Inc. | $28 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-11-12 | Takeda Pharmaceuticals U.S.A., Inc. | $23 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-11-12 | Takeda Pharmaceuticals U.S.A., Inc. | $6 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-11-12 | Takeda Pharmaceuticals U.S.A., Inc. | $4 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-11-11 | GlaxoSmithKline, LLC. | $25 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-11-11 | Janssen Biotech, Inc. | $22 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-11-07 | Biocon Biologics Inc | $34 | Food and Beverage | In-kind items and services | Ogivri Drug, Oncology | 2025 | |
| 2025-11-05 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-11-04 | SpringWorks Therapeutics, Inc. | $44 | Food and Beverage | In-kind items and services | OGSIVEO Drug, DESMOID TUMORS | 2025 | |
| 2025-11-03 | PFIZER INC. | $26 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-10-31 | Pharmacosmos Therapeutics Inc. | $27 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-10-29 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-10-27 | Incyte Corporation | $29 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2025 | |
| 2025-10-24 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | $1 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-10-21 | Genentech USA, Inc. | $33 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2025 | |
| 2025-10-17 | Stemline Therapeutics Inc. | $30 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-10-17 | Agios Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2025 | |
| 2025-10-17 | ARRAY BIOPHARMA INC | $19 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-10-16 | JAZZ PHARMACEUTICALS INC. | $38 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-10-15 | AstraZeneca Pharmaceuticals LP | $33 | Food and Beverage | In-kind items and services | TAGRISSO Drug, Oncology | 2025 | |
| 2025-10-14 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-10-14 | Tempus AI, Inc | $22 | Food and Beverage | In-kind items and services | XT CDX Device, ONCOLOGY | 2025 | |
| 2025-10-10 | Organon Llc | $32 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-10 | ABBVIE INC. | $2 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-10-09 | Astellas Pharma US Inc | $31 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-10-09 | Incyte Corporation | $23 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-10-02 | Syndax Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-30 | Celgene Corporation | $31 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-09-29 | Takeda Pharmaceuticals U.S.A., Inc. | $28 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-09-26 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-09-25 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-09-25 | Daiichi Sankyo Inc. | $28 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-09-23 | ARRAY BIOPHARMA INC | $23 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-09-22 | Caris MPI, Inc. | $23 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-09-18 | GENZYME CORPORATION | $64 | Food and Beverage | In-kind items and services | AYVAKIT Biological, Gastroenterology | 2025 | |
| 2025-09-18 | AstraZeneca Pharmaceuticals LP | $31 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-09-17 | Takeda Pharmaceuticals U.S.A., Inc. | $22 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-09-17 | Takeda Pharmaceuticals U.S.A., Inc. | $6 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-09-17 | Takeda Pharmaceuticals U.S.A., Inc. | $1 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-09-16 | Bayer Healthcare Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | Stivarga Drug, Oncology | 2025 | |
| 2025-09-15 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-09-15 | Fennec Pharmaceuticals, Inc. | $25 | Food and Beverage | In-kind items and services | Fyarro Drug, Cancer | 2025 | |
| 2025-09-12 | ADC THERAPEUTICS AMERICA, INC. | $17 | Food and Beverage | Cash or cash equivalent | ZYNLONTA Drug, ONCOLOGY | 2025 | |
| 2025-09-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-10 | Daiichi Sankyo Inc. | $19 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-09-09 | PharmaEssentia USA Corporation | $25 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-09-08 | AstraZeneca Pharmaceuticals LP | $32 | Food and Beverage | In-kind items and services | TAGRISSO Drug, Oncology | 2025 | |
| 2025-09-05 | Aveo Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-09-05 | Syndax Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-04 | Eisai Inc. | $20 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-09-02 | EMD Serono, Inc. | $18 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-08-29 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-08-29 | Takeda Pharmaceuticals U.S.A., Inc. | $1 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-08-28 | BeOne Medicines USA, Inc. | $23 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-08-27 | Stemline Therapeutics Inc. | $23 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-08-25 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-08-22 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-08-22 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | TAGRISSO Drug, Oncology | 2025 | |
| 2025-08-21 | Merck Sharp & Dohme LLC | $32 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-08-20 | GlaxoSmithKline, LLC. | $31 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-08-19 | Celgene Corporation | $20 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-08-15 | Janssen Biotech, Inc. | $29 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-08-14 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-08-13 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-08-12 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-08-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2025 | |
| 2025-08-08 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-08-07 | Lilly USA, LLC | $28 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-08-06 | Janssen Biotech, Inc. | $35 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-08-05 | Janssen Biotech, Inc. | $2 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-08-04 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-07-31 | Merck Sharp & Dohme LLC | $30 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-31 | SERVIER PHARMACEUTICALS LLC | $24 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2025 | |
| 2025-07-30 | Pharmacosmos Therapeutics Inc. | $20 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-07-29 | Takeda Pharmaceuticals U.S.A., Inc. | $26 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-07-29 | Takeda Pharmaceuticals U.S.A., Inc. | $0 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-07-25 | Coherus Oncology, Inc. | $34 | Food and Beverage | In-kind items and services | LOQTORZI Biological, Oncology | 2025 | |
| 2025-07-24 | Celgene Corporation | $28 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-07-24 | GlaxoSmithKline, LLC. | $28 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-07-22 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-07-18 | Syndax Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-16 | Coherus Oncology, Inc. | $35 | Food and Beverage | In-kind items and services | LOQTORZI Biological, Oncology | 2025 | |
| 2025-07-16 | Daiichi Sankyo Inc. | $28 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-07-15 | PFIZER INC. | $33 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-07-15 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-07-14 | Daiichi Sankyo Inc. | $23 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-07-10 | Organon Llc | $29 | Food and Beverage | In-kind items and services | ONTRUZANT Drug, TRASTUZUMAB | 2025 | |
| 2025-07-10 | GlaxoSmithKline, LLC. | $20 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-07-09 | TerSera Therapeutics LLC | $23 | Food and Beverage | In-kind items and services | Zoladex Drug, Oncology | 2025 | |
| 2025-07-08 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-07-08 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-07-07 | Verity Pharmaceuticals Inc. | $22 | Food and Beverage | Cash or cash equivalent | Trelstar Drug, Prostate cancer | 2025 | |
| 2025-07-07 | Takeda Pharmaceuticals U.S.A., Inc. | $21 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-07-07 | Takeda Pharmaceuticals U.S.A., Inc. | $7 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-07-07 | Takeda Pharmaceuticals U.S.A., Inc. | $0 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-07-03 | ACCORD HEALTHCARE, INC. | $26 | Food and Beverage | In-kind items and services | Camcevi Drug, Urology Oncology – GnRH agonist for treating adults with advanced prostate cancer | 2025 | |
| 2025-07-01 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage | In-kind items and services | TAGRISSO Drug, Oncology | 2025 | |
| 2025-06-30 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-06-27 | ARRAY BIOPHARMA INC | $35 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-06-27 | Alexion Pharmaceuticals, Inc. | $34 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-06-26 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-06-23 | Novocure Inc. | $16 | Food and Beverage | Cash or cash equivalent | Optune Lua (NovoTTF-200T) Device, Oncology | 2025 | |
| 2025-06-20 | JAZZ PHARMACEUTICALS INC. | $31 | Food and Beverage | In-kind items and services | ZIIHERA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-06-17 | E.R. Squibb & Sons, L.L.C. | $25 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-06-16 | Legend Biotech USA Inc. | $29 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-06-13 | Iovance Biotherapeutics, Inc. | $29 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-06-13 | ARRAY BIOPHARMA INC | $21 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-06-11 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-06-10 | Spectrum Pharmaceuticals Inc. | $35 | Food and Beverage | In-kind items and services | ROLVEDON Drug, Oncology | 2025 | |
| 2025-06-09 | Caris MPI, Inc. | $27 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-06-06 | Aveo Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-06-06 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-06-06 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-06-03 | AstraZeneca Pharmaceuticals LP | $25 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-06-02 | Regeneron Healthcare Solutions, Inc. | $32 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-06-02 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-05-30 | PharmaEssentia USA Corporation | $25 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-05-30 | Takeda Pharmaceuticals U.S.A., Inc. | $15 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-05-30 | Takeda Pharmaceuticals U.S.A., Inc. | $1 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-05-29 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-28 | BeOne Medicines USA, Inc. | $31 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-05-27 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-27 | Celgene Corporation | $0 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-23 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-05-22 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-20 | Celgene Corporation | $30 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-20 | Daiichi Sankyo Inc. | $7 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-05-16 | Legend Biotech USA Inc. | $18 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-05-16 | Fresenius Kabi USA, LLC | $18 | Food and Beverage | In-kind items and services | Stimufend Biological, Biosimilars | 2025 | |
| 2025-05-15 | AstraZeneca Pharmaceuticals LP | $34 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-05-13 | Janssen Biotech, Inc. | $16 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-05-12 | Rigel Pharmaceuticals, Inc. | $18 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-05-08 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-05-08 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-05-07 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-05-06 | Exelixis Inc. | $33 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2025 | |
| 2025-05-05 | Eisai Inc. | $17 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-05-02 | Daiichi Sankyo Inc. | $26 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-05-02 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-05-02 | Celgene Corporation | $1 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-02 | Celgene Corporation | $0 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-05-01 | SERVIER PHARMACEUTICALS LLC | $19 | Food and Beverage | In-kind items and services | Voranigo Drug, Oncology | 2025 | |
| 2025-04-30 | SOBI, INC | $27 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-04-29 | Merck Sharp & Dohme LLC | $31 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-29 | Merck Sharp & Dohme LLC | $11 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-28 | Coherus Oncology, Inc. | $27 | Food and Beverage | In-kind items and services | LOQTORZI Biological, Oncology | 2025 | |
| 2025-04-24 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-04-24 | Daiichi Sankyo Inc. | $4 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-04-23 | Iovance Biotherapeutics, Inc. | $20 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-04-22 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-18 | Eisai Inc. | $26 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-04-18 | KYOWA KIRIN, INC. | $24 | Food and Beverage | In-kind items and services | POTELIGEO Drug, MONOCLONAL ANTIBODY | 2025 | |
| 2025-04-17 | Geron Corporation | $34 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-04-16 | Amneal Pharmaceuticals LLC | $29 | Food and Beverage | In-kind items and services | ALYMSYS Drug, ONCOLOGY | 2025 | |
| 2025-04-15 | Celgene Corporation | $32 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-04-13 | Fresenius Kabi USA, LLC | $27 | Food and Beverage | In-kind items and services | Stimufend Biological, Biosimilars | 2025 | |
| 2025-04-07 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-04-04 | Agios Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2025 | |
| 2025-04-03 | Genmab U.S., Inc. | $28 | Food and Beverage | In-kind items and services | Epkinly Drug, Oncology | 2025 | |
| 2025-04-02 | Eisai Inc. | $25 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-04-01 | Karyopharm Therapeutics Inc. | $21 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-03-31 | Takeda Pharmaceuticals U.S.A., Inc. | $10 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-03-31 | Takeda Pharmaceuticals U.S.A., Inc. | $7 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-03-31 | Takeda Pharmaceuticals U.S.A., Inc. | $2 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2025 | |
| 2025-03-28 | Janssen Biotech, Inc. | $33 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-03-28 | Legend Biotech USA Inc. | $29 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-03-27 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-03-26 | AstraZeneca Pharmaceuticals LP | $21 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-03-26 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-03-25 | TerSera Therapeutics LLC | $24 | Food and Beverage | In-kind items and services | Xermelo Drug, Oncology | 2025 | |
| 2025-03-21 | Janssen Biotech, Inc. | $32 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-03-21 | Janssen Biotech, Inc. | $1 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-03-20 | Geron Corporation | $20 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 |
The latest 200 records of 1,548.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2021-12-31 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $180 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2021 |
| 2020-11-24 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $100 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-11-24 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $50 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-11-24 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $100 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-10-26 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $60 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-10-26 | Merck Sharp & Dohme LLC | BAY AREA NCORP | $30 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
| 2020-09-28 | Merck Sharp & Dohme LLC | Bay Area Tumor Institute | $32 | A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Neg | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Antioch, CA, county Contra Costa County, CA, state California; placed by its city name.
| Measure | Place (city or town) Antioch, CA | County Contra Costa County, CA | State California |
|---|---|---|---|
| Population B01003 | 116,477 | 1,165,012 | 39,287,377 |
| Population, 2020 census P1 | 115,291 | 1,165,927 | 39,538,223 |
| Median age B01002 | 38.4 | 40.5 | 37.9 |
| Under 18 B01001 | 22.8% | 22.0% | 22.0% |
| 65 and over B01001 | 14.3% | 17.1% | 15.7% |
| Households B11001 | 37,381 | 414,417 | 13,548,091 |
| Foreign born B05002 | 24.6% | 26.6% | 27.0% |
| Median household income B19013 | $97,465 | $127,229 | $99,122 |
| Median family income B19113 | $109,115 | $148,679 | $113,346 |
| Per capita income B19301 | $41,008 | $62,927 | $49,513 |
| Poverty rate B17001 | 11.4% | 8.4% | 12.0% |
| Unemployment rate B23025 | 7.4% | 6.5% | 6.6% |
| Civilian labor force B23025 | 60,709 | 608,620 | 20,068,466 |
| Mean commute (minutes) B08013 | 42.0 | 35.3 | 28.7 |
| Bachelor's degree or higher B15003 | 23.9% | 45.2% | 37.1% |
| Housing units B25001 | 38,629 | 429,260 | 14,644,735 |
| Owner-occupied B25003 | 63.6% | 68.0% | 55.9% |
| Renters B25003 | 36.4% | 32.0% | 44.1% |
| Median home value B25077 | $629,700 | $866,800 | $734,700 |
| Median gross rent B25064 | $2,278 | $2,375 | $2,036 |
| White, not Hispanic B03002 | 23.4% | 38.1% | 33.8% |
| Black B03002 | 18.2% | 7.9% | 5.2% |
| Hispanic or Latino B03002 | 35.6% | 27.6% | 40.2% |
| Asian B03002 | 13.9% | 18.6% | 15.3% |
| American Indian and Alaska Native B03002 | 0.5% | 0.2% | 0.3% |
Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Antioch, CA.
Comments